Significant negative changes in Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) fundamentals have recently occurred: the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly.
Important negative changes in Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) investment behavior have recently occurred: negative upside/downside volume developed.
The stock is currently unrated.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, IRWD is expected to be a major Value Eraser.
Ironwood Pharmaceuticals is currently unrated.
Recent Price Action
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock declined modestly by -1.1% on 4/1/24. The stock closed at $8.61. However, exceptionally low trading volume at 47% of normal accompanied the decline. Relative to the market the stock has been strong over the last nine months but has declined -4.7% during the last week.